A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors
Molife, L Rhoda, Dean, Emma Jane, Blanco-Codesido, Montserrat, Krebs, Matthew G, Brunetto, Andre T, Greystoke, Alastair Peter, Daniele, Gennaro, Lee, Lucy, Kuznetsov, Galina, Myint, Khin Than, Wood, Karen, de Las Heras, Begoña, Ranson, Malcolm Richard
Published in Clinical cancer research (15.12.2014)
Published in Clinical cancer research (15.12.2014)
Get full text
Journal Article